Literature DB >> 22991070

Update on progressive multifocal leukoencephalopathy.

Israel Steiner1, Joseph R Berger.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a severe, often fatal, opportunistic viral infection of the central nervous system that is mainly seen in the context of AIDS and certain monoclonal immune-suppressive therapies. The causative agent, a polyoma virus, named JC virus infects only humans and there is no animal model for PML. This update focuses on information gathered in recent years on the pathogenesis of the disorder, on several clinical aspects associated with diagnosis and therapy, and on the immune reconstitution inflammatory syndrome (IRIS), a complication associated with removal of immunosuppressive therapy in PML.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22991070     DOI: 10.1007/s11910-012-0313-4

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  76 in total

1.  Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.

Authors:  Juan Berenguer; Pilar Miralles; Julio Arrizabalaga; Esteban Ribera; Fernando Dronda; Josu Baraia-Etxaburu; Pere Domingo; Manuel Márquez; Francisco J Rodriguez-Arrondo; Fernando Laguna; Rafael Rubio; José Lacruz Rodrigo; J Mallolas; Verónica de Miguel
Journal:  Clin Infect Dis       Date:  2003-04-02       Impact factor: 9.079

2.  Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.

Authors:  Gert Van Assche; Marc Van Ranst; Raf Sciot; Bénédicte Dubois; Séverine Vermeire; Maja Noman; Jannick Verbeeck; Karel Geboes; Wim Robberecht; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

3.  The bone marrow, B cells, and JC virus.

Authors:  Sidney A Houff; Joseph R Berger
Journal:  J Neurovirol       Date:  2008-10-16       Impact factor: 2.643

4.  JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

Authors:  I J Koralnik; R A Du Pasquier; N L Letvin
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individuals.

Authors:  R Caldarelli-Stefano; L Vago; E Omodeo-Zorini; M Mediati; L Losciale; M Nebuloni; G Costanzi; P Ferrante
Journal:  J Neurovirol       Date:  1999-04       Impact factor: 2.643

6.  Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy.

Authors:  Cesare Giovanni Fedele; Maria Rosa Ciardi; Salvatore Delia; Gerardo Contreras; José Luis Perez; Maria De Oña; Elisa Vidal; Antonio Tenorio
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

7.  Seroepidemiology of the human polyomaviruses.

Authors:  Annika Stolt; Kestutis Sasnauskas; Pentti Koskela; Matti Lehtinen; Joakim Dillner
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

Review 8.  T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of action.

Authors:  D Jullien; J C Prinz; R G B Langley; I Caro; W Dummer; A Joshi; R Dedrick; P Natta
Journal:  Dermatology       Date:  2004       Impact factor: 5.366

9.  Identification and characterization of mefloquine efficacy against JC virus in vitro.

Authors:  Margot Brickelmaier; Alexey Lugovskoy; Ramya Kartikeyan; Marta M Reviriego-Mendoza; Norm Allaire; Kenneth Simon; Richard J Frisque; Leonid Gorelik
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

10.  Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML).

Authors:  Shamil R Sunyaev; Alexey Lugovskoy; Kenneth Simon; Leonid Gorelik
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

View more
  12 in total

1.  Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Robert Hoepner; Stefanie Dahlhaus; Susanne Kollar; Barbara Zurawski; Andrew Chan; Ingo Kleiter; Ralf Gold; Kerstin Hellwig
Journal:  Ther Adv Neurol Disord       Date:  2014-01       Impact factor: 6.570

2.  PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents.

Authors:  Kiran M Kanth; Guillermo E Solorzano; Myla D Goldman
Journal:  Neurol Clin Pract       Date:  2016-04

3.  Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.

Authors:  Eileen M Geoghegan; Diana V Pastrana; Rachel M Schowalter; Upasana Ray; Wei Gao; Mitchell Ho; Gary T Pauly; Dina M Sigano; Campbell Kaynor; Ellen Cahir-McFarland; Benoit Combaluzier; Jan Grimm; Christopher B Buck
Journal:  Cell Rep       Date:  2017-10-31       Impact factor: 9.423

4.  Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.

Authors:  Rebekka Kurmann; Christian Weisstanner; Piotr Kardas; Hans H Hirsch; Roland Wiest; Bernhard Lämmle; Hansjakob Furrer; Renaud Du Pasquier; Claudio L Bassetti; Mathias Sturzenegger; Heinz Krestel
Journal:  J Neurovirol       Date:  2015-04-28       Impact factor: 2.643

5.  Pseudovirus mimics cell entry and trafficking of the human polyomavirus JCPyV.

Authors:  Gretchen V Gee; Bethany A O'Hara; Aaron Derdowski; Walter J Atwood
Journal:  Virus Res       Date:  2013-10-04       Impact factor: 3.303

6.  5-HT2 receptors facilitate JC polyomavirus entry.

Authors:  Benedetta Assetta; Melissa S Maginnis; Irene Gracia Ahufinger; Sheila A Haley; Gretchen V Gee; Christian D S Nelson; Bethany A O'Hara; Stacy-ann A Allen Ramdial; Walter J Atwood
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

Review 7.  JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.

Authors:  Melissa S Maginnis; Christian D S Nelson; Walter J Atwood
Journal:  J Neurovirol       Date:  2014-07-31       Impact factor: 2.643

Review 8.  Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature.

Authors:  Martijn T Wijburg; Bob W van Oosten; Jean-Luc Murk; Ouafae Karimi; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2014-10-09       Impact factor: 6.682

9.  Maraviroc in PML-IRIS: A separate ball game under HIV infection and natalizumab?

Authors:  Israel Steiner; Felix Benninger
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-02-08

10.  Concomitant granule cell neuronopathy in patients with natalizumab-associated PML.

Authors:  Martijn T Wijburg; Dorine Siepman; Jeroen J J van Eijk; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-01-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.